Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline
JCI Insight · 2023
DOI: 10.1172/jci.insight.166175 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Jing Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology and. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Hepcidins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Elderly individuals frequently report cognitive decline, while various studies indicate hippocampal functional declines with advancing age. Hippocampal function is influenced by ghrelin through hippocampus-expressed growth hormone secretagogue receptor (GHSR). Liver-expressed antimicrobial peptide 2 (LEAP2) is an endogenous GHSR antagonist that attenuates ghrelin signaling. Here, we measured plasma ghrelin and LEAP2 levels in a cohort of cognitively normal individuals older than 60 and found that LEAP2 increased with age while ghrelin (also referred to in literature as "acyl-ghrelin") marginally declined. In this cohort, plasma LEAP2/ghrelin molar ratios were inversely associated with Mini-Mental State Examination scores. Studies in mice showed an age-dependent inverse relationship between plasma LEAP2/ghrelin molar ratio and hippocampal lesions. In aged mice, restoration of the LEAP2/ghrelin balance to youth-associated levels with lentiviral shRNA Leap2 downregulation improved cognitive performance and mitigated various age-related hippocampal deficiencies such as CA1 region synaptic loss, declines in neurogenesis, and neuroinflammation. Our data collectively suggest that LEAP2/ghrelin molar ratio elevation may adversely affect hippocampal function and, consequently, cognitive performance; thus, it may serve as a biomarker of age-related cognitive decline. Moreover, targeting LEAP2 and ghrelin in a manner that lowers the plasma LEAP2/ghrelin molar ratio could benefit cognitive performance in elderly individuals for rejuvenation of memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology and.
- Higuchi Biosciences Center, University of Kansas, Lawrence, Kansas, USA.
- Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Departments of Internal Medicine and Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- BrightFocus Foundation
- Higuchi Biosciences Center research grant
- KU career development grant
Zitieren
APA
Tian, J., Guo, L., Wang, T., Jia, K., Swerdlow, R. H., Zigman, J. M., & Du, H. (2023). Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline. JCI Insight. https://doi.org/10.1172/jci.insight.166175
Vancouver
Tian J, Guo L, Wang T, Jia K, Swerdlow RH, Zigman JM, et al. Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline. JCI Insight. 2023. doi:10.1172/jci.insight.166175
BibTeX
@article{Tian2023,
author = {Tian, Jing and Guo, Lan and Wang, Tienju and Jia, Kun and Swerdlow, Russell H and Zigman, Jeffrey M and Du, Heng},
title = {Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline},
journal = {JCI Insight},
year = {2023},
doi = {10.1172/jci.insight.166175}
}
EUVIMED